Skip to content

Application to Predict Neonatal Apnea With Bradycardia

Application to Predict Neonatal Apnea With Bradycardia (APNeA Study)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06852053
Acronym
APNeA
Enrollment
25
Registered
2025-02-28
Start date
2026-09-01
Completion date
2027-12-31
Last updated
2026-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea Neonatal, Bradycardia Neonatal

Brief summary

This purpose of this study is to reduce or stop apneas and bradycardias in pre-term infants, before they occur using gentle stimulation.

Detailed description

This will be a randomized cross-over trial that will use additional ECG leads connected to a novel device and laptop to determine the accuracy and efficacy of an algorithm to predict, detect, and interrupt episodes of bradycardia for two 4-hour periods. There will be a 4-hour period without vibro-tactile stimulation and a 4-hour period with vibro-tactile stimulation when episodes are predicted or detected.

Interventions

DEVICEClosed-loop Vibro-Tactile Stimulator

Vibro-Tactile stimulation when bradycardia is predicted or predicted.

DEVICEControl

Sham closed-loop vibrotactile stimulator

Sponsors

University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
22 Weeks to 32 Weeks
Healthy volunteers
No

Inclusion criteria

* Documented episodes of apnea with bradycardia over the previous 24 hours. * Off ventilatory support/NCPAP for \> 48 hours prior to study entry * Gestational age \< 32 0/7 weeks' gestation at birth * Parents/legal guardians have provided consent for enrollment

Exclusion criteria

* a major malformation or a neuromuscular condition that affects respiration or causes apnea, or terminal illness or decision to withhold or limit support.

Design outcomes

Primary

MeasureTime frameDescription
Bradycardia <100 beats per minute ≥ 10 seconds4-hours on either intervention.The frequency of episodes of bradycardia (heart rate less than 100 of ≥ 10 seconds) in either study arm during the study period.

Secondary

MeasureTime frameDescription
Bradycardia <60 beats per minute ≥ 5 seconds4 hours in either intervention.The frequency of episodes of bradycardia (heart rate \<60 beats per minute ≥ 5 seconds) in either study arm during the study period.
Bradycardia <60 beats per minute ≥ 10 seconds4 hours on either intervention.The frequency of episodes of bradycardia (heart rate \<60 beats per minute ≥ 10 seconds) in either study arm during the study period.
Bradycardia <80 beats per minute ≥ 5 seconds4 hours on either intervention.The frequency of episodes of bradycardia (heart rate \<80 beats per minute ≥ 5 seconds) in either study arm during the study period.
Bradycardia <80 beats per minute ≥ 10 seconds4 hours on either intervention.The frequency of episodes of bradycardia (heart rate \<80 beats per minute ≥ 10 seconds) in either study arm during the study period.
Proportion of time with Bradycardia < 100 beats per minute4 hours on either intervention.The total proportion of time with bradycardia during the study period on either intervention with a heartrate of \<100 beats per minute.
Hypoxemia <85% for ≥ 5 seconds4 hours on either intervention.The frequency of episodes of hypoxemia (oxygen saturations \<85% for ≥ 5 seconds) in either study arm during the study period.
Hypoxemia <85% for ≥ 10 seconds4 hours on either intervention.The frequency of episodes of hypoxemia (oxygen saturations \<85% for ≥ 10 seconds) in either study arm during the study period.
Hypoxemia <90% for ≥ 5 seconds4 hours on either intervention.The frequency of episodes of hypoxemia (oxygen saturations \<90% for ≥ 5 seconds) in either study arm during the study period.
Hypoxemia <90% for ≥ 10 seconds4 hours on either intervention.The frequency of episodes of hypoxemia (oxygen saturations \<90% for ≥ 10 seconds) in either study arm during the study period.
Hypoxemia <80% for ≥ 5 seconds4 hours on either intervention.The frequency of episodes of hypoxemia (oxygen saturations \<80% for ≥ 5 seconds) in either study arm during the study period.
Hypoxemia <80% for ≥ 10 seconds4 hours on either intervention.The frequency of episodes of hypoxemia (oxygen saturations \<80% for ≥ 10 seconds) in either study arm during the study period.
Proportion of time with hypoxemia < 90%4 hours on either intervention.The total proportion of time with oxygen saturations \<90% during the study period on either intervention.
Bradycardia prediction time4 hours on either intervention.The number of seconds ahead of routine patient monitors at which the device algorithm predicted bradycardia in either group.
Bradycardia prediction accuracy4 hours on sham control.The area under the curve for the true prediction rate over the false alarm rate in the control group.
Proportion of time with hypoxemia < 85%4 hours on either intervention.The total proportion of time with oxygen saturations \<85% during the study period on either intervention.

Countries

United States

Contacts

CONTACTRachel L. Benz, Clinical Research Nurse Manager, MSN
rlbenz@uabmc.edu205-934-2184
CONTACTKimberly M. Armstead Clinical Research Coordinator III, B.S.
karmstead@uabmc.edu205-934-0095
PRINCIPAL_INVESTIGATORColm P. Travers Associate Professor of Pediatrics, M.D.

University of Alabama at Birmingham

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 8, 2026